首页> 外文期刊>Dose-response >Clinical application of ischemic preconditioning in the elderly
【24h】

Clinical application of ischemic preconditioning in the elderly

机译:老年人缺血预处理的临床应用

获取原文
获取原文并翻译 | 示例
       

摘要

A mild stress such as brief ischemic episodes may protect the heart from a successive and more prolonged myocardial ischemia (ischemic preconditioning). This phenomenon is considered a typical "hormetic mechanism" by which the heart is immunized from pathological insults such as myocardial ischemia. This mechanism is reduced with aging and it may be restored and/or preserved by drugs such as adenosine or nicorandil, a mitochondrial K ATP channels, and lifestyle interventions such as physical activity and/or hypocaloric diet. Moreover, since the mechanisms involved in cardiac ischemic preconditioning have been established basic and clinical investigators are encouraged to test several drug in well-controlled animal and human studies in order to prevent and/or restore the age-related reduction of ischemic preconditioning.
机译:轻度的压力(例如短暂的缺血性发作)可以保护心脏免受连续性和更长时间的心肌缺血(缺血预处理)的影响。这种现象被认为是典型的“抑制机制”,通过该机制免疫心脏免受诸如心肌缺血之类的病理损伤。该机制随着衰老而降低,并且可以通过诸如腺苷或尼可地尔的药物,线粒体K ATP通道和生活方式干预(例如体育活动和/或低热量饮食)来恢复和/或保存。此外,由于已经建立了涉及心脏缺血预处理的机制,因此,鼓励临床研究人员在控制良好的动物和人体研究中测试几种药物,以预防和/或恢复与年龄有关的缺血预处理的减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号